Related Experiment Videos

[Purulent meningitis in children: special considerations for developing countries]

P Reinert1

  • 1Service de pédiatrie, Centre Hospitalier Intercommunal de Créteil, 40 avenue de Verdun, 94010 Créteil. philippe.reinert@chicreteil.fr

Medecine Tropicale : Revue Du Corps De Sante Colonial
|February 7, 2004
PubMed

Insights

Bacterial meningitis is a significant threat in tropical regions due to epidemics and lack of vaccination. New vaccines combining Haemophilus influenzae type b, meningococcal types a and W135, and pneumococcal serotypes are crucial for improved child immunization.

Area of Science:

  • Tropical infectious diseases
  • Vaccinology
  • Epidemiology

Context:

  • Bacterial meningitis, particularly meningococcal and pneumococcal, poses a significant public health challenge in tropical zones, exacerbated by recurring epidemics and limited vaccination coverage.
  • The emergence of antibiotic-resistant strains of Streptococcus pneumoniae and the unexplained rise of Neisseria meningitidis W135 strains in Burkina Faso complicate treatment and control efforts.

Purpose:

  • To highlight the epidemiological challenges of bacterial meningitis in tropical regions.
  • To discuss the limitations of current vaccines and the need for broader coverage.
  • To advocate for the development and implementation of comprehensive conjugate vaccines.

Summary:

  • Bacterial meningitis is prevalent in tropical areas, driven by meningococcal epidemics and inadequate Haemophilus influenzae type b (Hib) vaccination.
  • The emergence of meningococcal W135 and antibiotic-resistant pneumococcal strains increases disease burden and treatment costs.
  • A future conjugate vaccine combining Hib, meningococcal A and W135, and additional pneumococcal serotypes is proposed to enhance protection.

Impact:

  • Improved immunization strategies are essential to reduce the incidence and mortality of bacterial meningitis in tropical regions.
  • The development of a multi-valent conjugate vaccine could significantly increase vaccine effectiveness against key meningitis pathogens.
  • Achieving 85% coverage for pneumococcal meningitis may require a vaccine including four additional serotypes beyond the current 7-valent formulation.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...